We are live on ! Find out more
TC

Trilogy Capital Portfolio holdings

AUM $2.58B
1-Year Est. Return 22.97%
This Fund
S&P 500
This Quarter Est. Return
+7.51%
1 Year Est. Return
+22.97%
3 Year Est. Return
+54.11%
5 Year Est. Return
+45.31%
10 Year Est. Return
AUM
$1.41B
AUM Growth
+$294M
Cap. Flow
+$224M
Cap. Flow %
15.92%
Top 10 Hldgs %
35.83%
Holding
251
New
74
Increased
119
Reduced
43
Closed
11
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWP icon
151
iShares Russell Mid-Cap Growth ETF
IWP
$19.8B
$610K 0.04%
+7,292
New +$614K
RSP icon
152
Invesco S&P 500 Equal Weight ETF
RSP
$97B
$542K 0.04%
3,837
-667
-15% -$93.3K
SPHY icon
153
State Street SPDR Portfolio High Yield Bond ETF
SPHY
$11.5B
$531K 0.04%
23,748
-3,317
-12% -$74.2K
SLYG icon
154
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.06B
$525K 0.04%
7,263
-1,261
-15% -$92.8K
AMZN icon
155
Amazon
AMZN
$2.5T
$516K 0.04%
6,141
+361
+6% +$35.7K
IWM icon
156
iShares Russell 2000 ETF
IWM
$80.3B
$514K 0.04%
2,949
+852
+41% +$152K
EFA icon
157
iShares MSCI EAFE ETF
EFA
$76.8B
$477K 0.03%
7,273
-414
-5% -$25.9K
XLG icon
158
Invesco S&P 500 Top 50 ETF
XLG
$10.5B
$460K 0.03%
+16,670
New +$470K
AVUV icon
159
Avantis US Small Cap Value ETF
AVUV
$30.3B
$458K 0.03%
6,147
-285
-4% -$21.4K
GWX icon
160
State Street SPDR S&P International Small Cap ETF
GWX
$862M
$455K 0.03%
15,486
+708
+5% +$20K
SMDV icon
161
ProShares Russell 2000 Dividend Growers ETF
SMDV
$701M
$452K 0.03%
+7,368
New +$454K
IAU icon
162
iShares Gold Trust
IAU
$63.4B
$449K 0.03%
+12,988
New +$427K
IWS icon
163
iShares Russell Mid-Cap Value ETF
IWS
$15.6B
$446K 0.03%
4,231
-235
-5% -$24.6K
IEMG icon
164
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
$442K 0.03%
9,473
+2,639
+39% +$120K
PEP icon
165
PepsiCo
PEP
$190B
$440K 0.03%
2,434
+285
+13% +$50.8K
JNJ icon
166
Johnson & Johnson
JNJ
$643B
$435K 0.03%
2,460
+703
+40% +$121K
ESGE icon
167
iShares ESG Aware MSCI EM ETF
ESGE
$6.52B
$425K 0.03%
14,134
-407
-3% -$11.9K
SPMV
168
DELISTED
Invesco S&P 500 Minimum Variance ETF
SPMV
$425K 0.03%
11,652
-387
-3% -$14K
SRLN icon
169
State Street Blackstone Senior Loan ETF
SRLN
$5.3B
$421K 0.03%
10,291
+639
+7% +$26.3K
GIS icon
170
General Mills
GIS
$19.5B
$409K 0.03%
4,879
+1,912
+64% +$156K
JPM icon
171
JPMorgan Chase
JPM
$945B
$403K 0.03%
+3,004
New +$381K
MS icon
172
Morgan Stanley
MS
$335B
$402K 0.03%
4,728
PSMG
173
DELISTED
Invesco Growth Multi-Asset Allocation ETF
PSMG
$385K 0.03%
23,609
+5,369
+29% +$86.7K
BIV icon
174
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
$384K 0.03%
5,167
-92,883
-95% -$6.88M
EEMV icon
175
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.46B
$372K 0.03%
7,018
+483
+7% +$25.3K

Similar funds

Trilogy Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Trilogy Capital held 251 positions worth $1.41B, up 26% from $1.12B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Trilogy Capital deployed $224M of net new capital in Q4 2022, opening 74 new positions and adding to 119 existing holdings. Its largest new stake was THOR Low Volatility ETF: 1,325,297 shares worth $32.7M.

By sector, the portfolio is most concentrated in Utilities at 1.3% of assets, up from 1.1% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was iShares Core Conservative Allocation ETF, an estimated $155M trimmed.

  • Trilogy Capital's largest Q4 2022 buy was THOR Low Volatility ETF: 1,325,297 shares worth $32.7M.
  • Trilogy Capital added most to Invesco S&P 500 Quality ETF in Q4 2022, an estimated $33.3M increase.
  • Trilogy Capital's biggest Q4 2022 reduction was iShares Core Conservative Allocation ETF, cutting an estimated $155M.
  • Trilogy Capital fully exited iShares iBonds Dec 2022 Term Treasury ETF in Q4 2022, selling an estimated $6.68M.
  • Trilogy Capital's ten largest holdings make up 36% of its $1.41B portfolio in Q4 2022.
  • Trilogy Capital opened 74 new positions and closed 11 in Q4 2022.
  • Trilogy Capital's portfolio value rose 26% quarter-over-quarter to $1.41B.

Based on Trilogy Capital's 13F filing for Q4 2022, filed 9 Feb 2023.